
Rajeev Venkayya, Aerium Therapeutics CEO
Born out of Omega push for pandemic treatments, Aerium Therapeutics enters long Covid R&D
Aerium Therapeutics, which Omega Funds seeded in 2021 and unveiled in spring 2022 to take on Covid-19 with new monoclonal antibodies, will attempt to treat …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.